Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;11(8):283-286.
doi: 10.5489/cuaj.4140.

Implications of prostate-specific antigen screening guidelines on clinical practice at a Canadian regional community hospital

Todd M Webster  1 , Erika Lau  2 , Ken J Newell  2
Affiliations

Implications of prostate-specific antigen screening guidelines on clinical practice at a Canadian regional community hospital

Todd M Webster et al. Can Urol Assoc J. 2017 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors report no competing personal or financial interests.

Figures

Fig. 1
Fig. 1
Numbers of prostate-specific antigen (PSA) followups and PSA screening tests, 2009–2015.
Fig. 2
Fig. 2
Numbers of prostate-specific antigen (PSA) followups and PSA screening tests, 2009–2015.
See this image and copyright information in PMC

References

    1. Canadian Cancer Society Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2013. Toronto: Canadian Cancer Society; 2013.
    1. Canadian Task Force on Preventive Health Care. Bell N, Connor Gorber S, Shane A, et al. Recommendations on screening for prostate cancer with the prostate-specific antigen test. CMAJ. 2014;186:1225–34. - PMC - PubMed
    1. Moyer VA U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120–34. https://doi.org/10.7326/0003-4819-157-2-201207170-00459. - DOI - PubMed
    1. Schröder FH, Hugosson J, Carlsson S, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Eur Urol. 2012;62:745–52. https://doi.org/10.1016/j.eururo.2012.05.068. - DOI - PubMed
    1. Morash C, Tey R, Agbassi C, et al. Evidence-based series 17–9, A quality initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario(CCO) Active Surveillance for the Management of Localized Prostate Cancer. 2014. [Accessed July 10, 2017]. Available at https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=325696.

LinkOut - more resources